Stock Analysts’ updated eps estimates for Friday, May 24th:

Bright Scholar Education Holdngs (NYSE:BEDU) was downgraded by analysts at Morgan Stanley from an equal rating to a weight rating.

Citigroup Inc assumed coverage on shares of Cellectis (NASDAQ:CLLS). The firm issued a neutral rating and a $22.00 price target on the stock.

Wolfe Research started coverage on shares of Enanta Pharmaceuticals (NASDAQ:ENTA). Wolfe Research issued an outperform rating and a $117.00 price target on the stock.

Northcoast Research initiated coverage on shares of EVO Payments (NASDAQ:EVOP). They issued a neutral rating on the stock.

Citigroup Inc started coverage on shares of Fate Therapeutics (NASDAQ:FATE). They issued a buy rating and a $26.00 target price on the stock.

Citigroup Inc initiated coverage on shares of Harpoon Therapeutics (NASDAQ:HARP). They issued a buy rating and a $23.00 price target on the stock.

Nordstrom (NYSE:JWN) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Nordstrom underperformed the industry in the past six months due to a soft gross margin trend. The stock came under pressure when the company reported dismal first-quarter fiscal 2019 results and trimmed view for the fiscal year. While its earnings missed estimates after four consecutive beats, sales lagged for the second straight quarter. Results were hurt by the persistence of soft sales trends in full-price stores in the fiscal first quarter. Moreover, the top line was hurt by the company’s loyalty program, digital marketing and merchandise. These factors also contributed to a slower rate of growth in digital sales in comparison with the last fiscal year. Higher expenses for store openings, technology and supply chain are added concerns. Nevertheless, Nordstrom’s store-expansion efforts and customer-based strategy appear encouraging. Also, the company remains on track to accomplish its financial targets by 2020.”

Kloeckner & Co SE (ETR:KCO) had its neutral rating reiterated by analysts at DZ Bank AG.

Kohl’s (NYSE:KSS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Kohl's shares have lagged the industry in the past three months. Pressure on the stock increased after it posted dismal first-quarter fiscal 2019 results, wherein both top and bottom lines fell year over year and missed the Zacks Consensus Estimate. Notably, this marked Kohl’s first earnings and revenue miss in a long time. Comps also broke the strong trend owing to adverse weather condition, weak home category sales and not so productive promotions amid intense competition. The company expects the softness to continue in the second quarter. These hurdles and expected tariff impacts compelled management to slash its outlook. Nonetheless, Kohl’s is on track to improve sales in the second half of the fiscal on the back of the Amazon Returns program and other sales-driving endeavors. Also, the company’s inventory management efforts should cushion gross margin.”

Edward Jones assumed coverage on shares of Kontoor Brands (NYSE:KTB). They issued a hold rating on the stock.

HSBC Holdings plc started coverage on shares of MARKS & SPENCER/S (OTCMKTS:MAKSY). They issued a hold rating on the stock.

NeoPhotonics (NYSE:NPTN) had its buy rating reiterated by analysts at Craig Hallum. Craig Hallum currently has a $6.00 target price on the stock, down from their previous target price of $11.00.

RTL Group (EBR:RTL) had its neutral rating reiterated by analysts at DZ Bank AG.

RYB Education (NYSE:RYB) was downgraded by analysts at Morgan Stanley from an equal rating to a weight rating.

Citigroup Inc started coverage on shares of Acceleron Pharma (NASDAQ:XLRN). The firm issued a buy rating and a $66.00 price target on the stock.

Receive News & Ratings for Bright Scholar Education Holdngs Ltd-ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Scholar Education Holdngs Ltd-ADR and related companies with MarketBeat.com's FREE daily email newsletter.